Biomarkers for mitochondrial respiratory chain disorders

Area of Science:

• Biochemistry
• Genetics
• Molecular Biology

Background:

• Mitochondrial respiratory chain deficiencies encompass over 100 disorders with diverse clinical presentations in all age groups.
• Despite advances in understanding their genetic basis, diagnosing these conditions remains difficult.
• Current diagnostic standards rely heavily on invasive muscle biopsies, highlighting the need for less invasive methods.

Purpose of the Study:

• To explore novel diagnostic approaches for mitochondrial respiratory chain disorders.
• To investigate the potential of serum biomarkers for improved diagnostic sensitivity and specificity.
• To leverage recent technological advancements for identifying molecular signatures of these deficiencies.

Main Methods:

• Utilizing advanced mass spectrometry for analyzing patient samples.
• Employing transcriptomic, proteomic, and metabolomic approaches.
• Studying genetically modified mouse models to understand disease pathophysiology.

Main Results:

• Technological advancements enable the identification of molecular consequences of mitochondrial dysfunction.
• Emerging disease models provide valuable insights into disease mechanisms.
• Potential molecular signals and metabolic fingerprints have been identified.

Conclusions:

• Identified molecular signals and metabolic fingerprints show promise as future diagnostic biomarkers.
• Novel diagnostic tools based on serum biomarkers could overcome current limitations.
• Further research holds the potential to revolutionize the diagnosis of mitochondrial respiratory chain disorders.